← Return to Something new in the treatment arsenal?

Discussion

Something new in the treatment arsenal?

Breast Cancer | Last Active: Aug 7 11:34am | Replies (61)
Comment receiving replies
@californiazebra

@nlb122 thanks for sharing!
I just looked it up and it's for HR+ HER2 low or negative breast cancer. They also had similar results with it for non-small cell lung cancer. Sounds promising for lots of people. I didn't see any actual data so I wonder how is compares to PFS time achieved with Kisqali, Ibrance and Verzenio? If anyone sees the progression free survival (PFS) time posted, please post here. Thanks!

Jump to this post

Replies to "@nlb122 thanks for sharing! I just looked it up and it's for HR+ HER2 low or..."
anjalima | @anjalima | Sep 25, 2023

I think it’s not “mature” enough data … not enough years to evaluate relative to meds in the field for longer. Even Verzenio Ry al’s do not have “ mature” data.

Looking very promising however. I’m sure it will be a huge topic at the San Antonio Breast Cancer Symposium in December.

VIEW AND REPLY